Literature DB >> 33423969

Prognostic value of platelet-associated biomarkers in rectal cancer patients received neoadjuvant chemoradiation: A retrospective study.

P Wang1, Z Wang2, Y Liu3, J Xie1, Y Ren4.   

Abstract

PURPOSE: Platelet volume has been shown to prognostic value in patients with colorectal cancer. However, the changes of other platelet-associated biomarkers in rectal cancer patients, before and after the neoadjuvant chemoradiation therapy (NACRT), remain unclear. In this study, we investigated the prognostic value of platelet-associated biomarkers in rectal cancer patients with NACRT. PATIENTS AND METHODS: A total of 75 patients with locally advanced (T3-4 or N+) rectal cancer (LARC) cancer were selected and followed up from the Affiliated Cancer Hospital of Zhengzhou University between June 2013 and September 2016. The data of platelet-associated biomarkers, including the platelet count, platelet to lymphocyte ratio (PLR), lymphocyte to monocyte ratio (LMR), mean platelet volume (MPV), and platelet distribution width (PDW) both pre- and post- NACRT, were collected. The associations between these platelet-associated biomarkers and the overall survival (OS), as well as disease-free survival (DFS) of patients, were analysed. Patients were divided into groups with high or low values of the platelet-associated biomarkers, and the outcomes were compared by using Cox regression and Kaplan-Meier analysis.
RESULTS: We found that pre-PLR (HR: 4.104; 95%CI: 1.411-11.421; P=0.009) and pre-LMR (HR: 0.384; 95%CI: 0.124-1.185; P=0.066) could predict the OS in LARC patients after NACRT by multivariate Cox regression analysis, a cut-off value of pre-PLR>7.02 and pre-LMR ≤7.10 could be used as independent prognostic factors for OS by Kaplan-Meier method. The pre-MPV value could be used as an independent prognostic factor for DFS by Kaplan-Meier analysis (P=0.037). Moreover, post-CEA was correlated with OS and DFS in LARC patients with NACRT.
CONCLUSION: In LARC patients with NACRT, the pre-PLR and pre-LMR are independent prognostic factors for OS, while pre-MPV has predictive value for DFS.
Copyright © 2020. Published by Elsevier Masson SAS.

Entities:  

Keywords:  Biomarqueurs associés aux plaquettes; Cancer du rectum; Chimioradiothérapie néoadjuvante; Neoadjuvant chemotherapy; Platelet-associated biomarkers; Prognosis; Pronostic; Rectal cancer; Survie; Survival

Mesh:

Substances:

Year:  2021        PMID: 33423969     DOI: 10.1016/j.canrad.2020.06.030

Source DB:  PubMed          Journal:  Cancer Radiother        ISSN: 1278-3218            Impact factor:   1.018


  3 in total

1.  Predictors and histological effects of preoperative chemoradiotherapy for rectal cancer and control of lateral lymph node metastasis.

Authors:  Hiroshi Miyakita; Lin Fung Chan; Kazutake Okada; Hajime Kayano; Masaki Mori; Sotaro Sadahiro; Seiichiro Yamamoto
Journal:  BMC Gastroenterol       Date:  2022-07-08       Impact factor: 2.847

2.  Histopathological and Haemogram Features Correlate with Prognosis in Rectal Cancer Patients Receiving Neoadjuvant Chemoradiation without Pathological Complete Response.

Authors:  Yu-Ming Huang; Hsi-Hsien Hsu; Chien-Kuo Liu; Ching-Kuo Yang; Po-Li Tsai; Tzu-Yin Tang; Shih-Ming Hsu; Yu-Jen Chen
Journal:  J Clin Med       Date:  2022-08-23       Impact factor: 4.964

3.  Combination of preoperative red cell distribution width and neutrophil to lymphocyte ratio as a prognostic marker for gastric cancer patients.

Authors:  Lei Fu; Qian Li; Qingxia Fan
Journal:  J Gastrointest Oncol       Date:  2021-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.